Xian Zhang

Fujian Provincial Key Laboratory Of Neurodegenerative Disease And Aging Research
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway.

FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway.

Journal: Neurobiology of disease

Published: August 13, 2025

Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.

Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 11, 2025

AI-Driven Revolution of Medical Robotics Across Surgical Innovation, Rehabilitation Intelligence, and Multimodal Healthcare Delivery.

AI-Driven Revolution of Medical Robotics Across Surgical Innovation, Rehabilitation Intelligence, and Multimodal Healthcare Delivery.

Journal: MedComm

Published: June 29, 2025

Soluble CSF1R alleviates microgliopathy in a CSF1R-related leukoencephalopathy (CRL) mouse model.

Soluble CSF1R alleviates microgliopathy in a CSF1R-related leukoencephalopathy (CRL) mouse model.

Journal: Journal of neuroinflammation

Published: April 02, 2025

Receptor-mediated endocytosis by Megalin: Exploring its role in ligand interaction and disease mechanisms.

Receptor-mediated endocytosis by Megalin: Exploring its role in ligand interaction and disease mechanisms.

Journal: Genes & diseases

Published: April 01, 2025

A strategy of microglia replacement alleviates microgliopathy in a CSF1R I794T hotspot mutation mouse model of CSF1R-related disorder.

A strategy of microglia replacement alleviates microgliopathy in a CSF1R I794T hotspot mutation mouse model of CSF1R-related disorder.

Journal: Cell reports. Medicine

Published: February 26, 2025

TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.

TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 03, 2025

Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies.

Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies.

Journal: Acta pharmaceutica Sinica. B

Published: January 21, 2025

Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R-Related Disorder (CSF1R-RD) in a Murine Model and CSF1R-RD Patients.

Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R-Related Disorder (CSF1R-RD) in a Murine Model and CSF1R-RD Patients.

Journal: Annals of neurology

Published: September 20, 2024

Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy.

Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy.

Journal: Translational psychiatry

Published: May 30, 2024

TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.

TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.

Journal: International immunopharmacology

Published: November 08, 2023

Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer's disease.

Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer's disease.

Journal: Zoological research

Published: August 03, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026